Source: Pharmacy Times articles
Intravenous immunoglobulin (IVIG) treatment for dermatologic conditions shows effectiveness but poses risks of kidney decline and thromboembolism, necessitating careful monitoring.
Read More
by MM360 Staff | May 7, 2025 | Myeloma News | 0 comments
Source: Pharmacy Times articles
Intravenous immunoglobulin (IVIG) treatment for dermatologic conditions shows effectiveness but poses risks of kidney decline and thromboembolism, necessitating careful monitoring.
Read More